Experience of using propafenone in newborns and young children with arrhythmias
Aim. To evaluate the efficacy and safety of propafenone therapy in newborns and young children, including children with congenital heart defects (CHD).Material and methods. The study included 65 children with initiation of propafenone therapy at the age of 0-5 years. For diagnosis of arrhythmias and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2020-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|